Christine Mikail Cvijic
CIK 1543663 · President and CFO · last filed 2026-05-08
Christine Mikail Cvijic is a President and CFO who has filed 20 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider sold $300.0K of NGNE on May 8, 2026. Across all open-market trades the lifetime net is −$144.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.86M
2
20
-$144.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGNE | President and CFO | 98,440 | $29.10 | $2.86M | -$144.9K | 9 | 2026-05-08 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | SVP, Legal Affairs & GC | — | — | — | $0 | 2 | 2015-02-24 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-08 | NGNE | Sell (S) | −9,600 | -$300.0K | EDGAR |
| 2026-03-30 | NGNE | Sell (S) | −2,558 | -$55.3K | EDGAR |
| 2026-03-17 | NGNE | Sell (S) | −4,045 | -$84.2K | EDGAR |
| 2026-03-03 | NGNE | Sell (S) | −4,800 | -$120.5K | EDGAR |
| 2026-02-24 | NGNE | Grant (A) | +22,000 | $0 | EDGAR |
| 2025-03-28 | NGNE | Grant (A) | +20,300 | $0 | EDGAR |
| 2025-03-17 | NGNE | Sell (S) | −4,501 | -$76.2K | EDGAR |
| 2024-11-25 | NGNE | Buy (P) | +24,000 | $491.4K | EDGAR |
| 2024-03-14 | NGNE | Grant (A) | +31,903 | $0 | EDGAR |
| 2016-05-03 | — | Grant (A) | — | $0 |